Science7 wrz 2026

Menopause and VO2max: What the Evidence Shows

A woman viewed from behind, hands on the handlebars of a stationary bike

Menopause changes far more than the menstrual cycle, and one of the things it touches is VO2max — the measure of aerobic fitness most closely tied to how long you live. Here is what the trial evidence actually shows, not what gets assumed about it.

Menopause changes far more than the menstrual cycle, and one of the things it touches is VO₂max — the measure of aerobic fitness most closely tied to how long you live. Here is what the trial evidence actually shows, not what gets assumed about it.

What happens to VO₂max during and after menopause?

Aerobic capacity falls with age in everyone, but the rate is measurable and not small. A 2026 scoping review pulled 29 studies spanning four decades of research on women masters athletes — competitive women over 40 — and found that 28 of them tracked aerobic capacity directly. The consistent finding was a decline of 0.36 to 0.84 mL·kg⁻¹·min⁻¹ per year, or roughly 0.5 to 2.4 percent a year, driven mainly by falling cardiac output and secondarily by changes in body composition (Vangsgaard et al., 2026). That is the decline seen in women who never stopped training. For someone whose activity also drops around midlife, the combined effect compounds.

Why would menopause affect aerobic fitness at all?

The proposed mechanism starts with hormones. Estrogen decline during the menopause transition is well established as a trigger for vasomotor symptoms, changes in body composition, and mood disturbance (Kurç & Tunalı Van Den Berg, 2026), and separately, the drop in ovarian hormones is linked to a rise in cardiovascular disease risk in the years after the final period (Huynh et al., 2024). Estrogen has known roles in vascular function and how efficiently the heart moves blood, which is the most direct route to a lower VO₂max.

A woman's face and raised arm, shown in black and white — Aerobic capacity falls by roughly 0.5 to 2.4 percent a year after 40, even in women who train competitively.

Here is the honest complication: that same 2026 scoping review, after synthesizing everything available on women masters athletes, concluded that the specific contribution of menopause — separate from ordinary aging — remains unclear. Training volume was a consistent predictor of preserved aerobic capacity; menopausal status was not a consistent one. The hormonal story is biologically plausible and supported by related markers like blood pressure and lipid changes, but a clean, isolated menopause effect on VO₂max specifically has not been demonstrated in long-term data. That gap is exactly why more longitudinal research on this population has been called for, rather than assumed to already exist.

Does aerobic exercise actually improve it?

Yes, and the effect size is one of the larger ones in the exercise literature. A systematic review and meta-analysis pooled 53 randomized controlled trials of aerobic training in postmenopausal women, totaling 3,821 participants aged 45 to 78. Cardiorespiratory fitness improved with a standardized mean difference of 1.38 (95% CI 1.13–1.64) — a large effect by any convention — alongside reductions in systolic blood pressure, resting heart rate, BMI, waist circumference, and LDL cholesterol, and an increase in HDL cholesterol (Huynh et al., 2024). The training programs varied widely: three to 21 sessions a week, 8 to 60 minutes a session, 3 to 52 weeks total. The certainty of evidence behind every one of those outcomes was rated very low, which is a genuine limitation of the underlying trials rather than a reason to dismiss a consistent pattern seen across 53 independent studies.

Does short, intense interval training work here too?

This is where the mechanistic evidence is more reassuring than most people expect. Reduced Exertion High-Intensity Interval Training (REHIT) and its relatives — brief, near-maximal cycling efforts separated by recovery, rather than long steady-state sessions — work by driving mitochondrial and capillary adaptation in skeletal muscle, which is the cellular basis for a higher VO₂max. A 2025 systematic review and meta-regression covering 353 studies and nearly 6,000 participants found that increases in mitochondrial content with training were not influenced by age, sex, menopause, or disease status. Sprint interval training built mitochondrial content about 2.3 times more efficiently per hour of exercise than moderate-intensity continuous training, and women showed significantly greater percentage gains in VO₂max than men from the same interval protocols (p = 0.008) (Mølmen et al., 2025).

A woman's shoulder and upper back, shown from behind in black and white — Sprint intervals raise mitochondrial content about 2.3 times more efficiently per hour than moderate, continuous cardio.

The plain-language version of that finding: the muscle's capacity to adapt to hard, short efforts does not appear to switch off at menopause. If anything, this dataset suggests women get a larger percentage return on interval work than men do, for the same time invested. That is a meaningfully different story than the vague idea that fitness gets harder to build after midlife regardless of what you do.

Is more intensity always the better choice?

No, and this is a case where the evidence pushes back on CAROL's own bias toward brief, intense training. A randomized controlled trial compared low-volume functional high-intensity interval training against a combined aerobic-and-resistance protocol, both run three times a week for 12 weeks in postmenopausal women, with blood pressure as the outcome. Combined training produced a significant reduction in systolic blood pressure from baseline; the interval group did not, and the between-group difference of 5.8 mmHg meant the two approaches were not statistically equivalent (Nunes et al., 2022). For blood pressure specifically, in this trial, more time spent walking and lifting beat less time spent going hard.

Does the delivery format matter?

Less than you might think. An eight-week randomized trial split 66 early postmenopausal women between supervised in-person combined training, an identical program delivered through a mobile app at home, and an education-only control. Predicted VO₂max improved in both exercise groups with similarly large effect sizes (d = 1.04 to 1.08), though only the app-based group reached significance after correction for multiple comparisons (Kurç & Tunalı Van Den Berg, 2026). Menopausal symptoms, fatigue, and sleep quality all improved in both groups too. The trial did not track adherence separately by group, which limits the comparison, but consistency looks like it matters more than supervision.

What about walking, or sticking with it for months rather than weeks?

Both have supporting data, at lower intensities than intervals or structured aerobic programs. A 12-week pilot trial had postmenopausal women walk five times a week at 50 to 60 percent of VO₂max, and it reduced triglycerides, fasting glucose, blood pressure, and waist circumference while raising HDL cholesterol, with the control group moving in the opposite direction on nearly every marker over the same period (Li et al., 2025). And a longer randomized trial of recreational team handball in postmenopausal women found that gains in aerobic performance made in the first 16 weeks held through 36 weeks, with lipid profile and physical fitness measures continuing to improve in the second half of the program (Pereira et al., 2023). Neither trial proves gentler or longer beats short and hard — both show the body keeps responding well past the first two months, in whatever form the training takes.

This article is general information, not medical advice. Menopause carries its own considerations around cardiovascular risk, bone density, and, for some, hormone therapy, and those are conversations to have with your doctor before you change how you train, particularly if you are adding high-intensity intervals for the first time.

The bottom line

VO₂max declines with age in women at a measurable, fairly consistent rate, and menopause is biologically plausible as a contributor, though a clean, isolated menopause effect has not been proven separately from ordinary aging (Vangsgaard et al., 2026). What is much better established is that the response to training stays intact: aerobic exercise reliably raises cardiorespiratory fitness in postmenopausal women (Huynh et al., 2024), the muscle's capacity for interval-driven adaptation is unaffected by menopausal status (Mølmen et al., 2025), and gains build over months, not just weeks (Pereira et al., 2023). The one caution worth keeping: intensity is not automatically the better lever for every outcome, and for blood pressure specifically, combined aerobic-and-resistance training outperformed a low-volume interval protocol in a head-to-head trial (Nunes et al., 2022). The honest summary is less dramatic than either "menopause ends your fitness" or "any exercise fixes it": your body's ability to adapt does not disappear, but which protocol earns its place still depends on what you are actually training for.